Joëlle Vermeulen

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2013) Chromatin and Epigenetics, EMBO Conference series, Abstracts.

Add to list

Identifying and validating DNA methylation biomarkers: the example of neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2013) Belgian Society of Human Genetics, 13th Annual meeting, Abstracts.

Add to list

Promoter methylation analysis identifies prognostic methylation biomarkers in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2012) ANR Toronto 2012, Abstracts.

Add to list

Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

A Schramm, B Schowe, K Fielitz, M Heilmann, M Martin, T Marschall, J Köster, Jo Vandesompele (UGent) , Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , et al.

(2012) BRITISH JOURNAL OF CANCER. 107(8). p.1409-1417

Add to list

Journal Article
A1
open access

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2012) GENOME BIOLOGY. 13(10).

Add to list

Journal Article
A1
open access

Measurable impact of RNA quality on gene expression results from quantitative PCR

Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , Steve Lefever (UGent) , Justine Nuytens (UGent) , Fanny De Vloed (UGent) , Stefaan Derveaux (UGent) , Jan Hellemans (UGent) , Franki Speleman (UGent) and Jo Vandesompele (UGent)

(2011) NUCLEIC ACIDS RESEARCH. 39(9).

Add to list

Journal Article
A1
open access

A 6-gene signature identifies four molecular subgroups of neuroblastoma

Frida Abel, Daniel Dalevi, Maria Nethander, Rebecka Jörnsten, Katleen De Preter (UGent) , Joëlle Vermeulen (UGent) , Raymond Stallings, Per Kogner, John Maris and Staffan Nilsson

(2011) CANCER CELL INTERNATIONAL. 11.

Add to list

miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

Katleen De Preter (UGent) , Pieter Mestdagh (UGent) , Joëlle Vermeulen (UGent) , Fjoralba Zeka (UGent) , Alene Naranjo, Isabella Bray, Victoria Castel, Caifu Chen, Elzbieta Drozynska, Angelika Eggert, et al.

(2011) CLINICAL CANCER RESEARCH. 17(24). p.7684-7692

Add to list

Journal Article
A1
open access

The microRNA body map : dissecting microRNA function through integrative genomics

Pieter Mestdagh (UGent) , Steve Lefever (UGent) , Filip Pattyn (UGent) , Dana Ridzon, Erik Fredlund, Annelies Fieuw (UGent) , Maté Ongenaert (UGent) , Joëlle Vermeulen (UGent) , Anne De Paepe (UGent) , Linda Wong, et al.

(2011) NUCLEIC ACIDS RESEARCH. 39(20).

Add to list

The miRNA body map: dissecting miRNA function through integrative genomics

Pieter Mestdagh (UGent) , Steve Lefever (UGent) , Filip Pattyn (UGent) , Dana Ridzon, Erik Fredlund, Annelies Fieuw (UGent) , Joëlle Vermeulen (UGent) , Anne De Paepe (UGent) , Linda Wong, Franki Speleman (UGent) , et al.

(2010) MicroRNAs Europe, Meeting abstracts.

Academic Bibliography

Joëlle Vermeulen

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Identifying and validating DNA methylation biomarkers: the example of neuroblastoma

Promoter methylation analysis identifies prognostic methylation biomarkers in neuroblastoma

Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Measurable impact of RNA quality on gene expression results from quantitative PCR

A 6-gene signature identifies four molecular subgroups of neuroblastoma

miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

The microRNA body map : dissecting microRNA function through integrative genomics

The miRNA body map: dissecting miRNA function through integrative genomics

Contents

Support

Contact